Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 08, 2014 12:50pm
201 Views
Post# 22539338

RE:RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...

RE:RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...SanFran...wow. Thanks for these perspectives...extremely valuable to me. I'm glad you are in a communication loop that helps with your insight.

I can only judge from posts on this site and my experience, so I'm glad you are in the loop.

It was me that came to the conclusion that the office colsolidation was a cost cutting measure to buy time. I thought they were just shutting one office and moving into some low cost consolidation. Thanks for the picture because it changes my perspective significantly and it does look like investment. The fact that it is within a neighbourhood of other office towers and near residential areas suggests they are doing this to create a pleasant work environment while addressing the lifestyle quality of their employees...what a great corporate attitude and a long term view. It suggests their are legs in this. The RVX & Zenith businesses are not suited for downtown Calgary.

Your idea of someone from Calgary visiting the offices and posting flicks is excellent as is Kelsee's idea for their website but as you've said before, when I mentioned my frustrations with lack of PR, they are limited in resourses. Of course the flip side of that is that great PR could support the share price...which is irrelavant if Don is well into cutting a deal.

I'm bouncing back and forth like a ping pong ball and yet I'm hopeful given the patents, intellectual capital and successful results. I need to forget about the short term share price other than picking up a few more shares.

Regarding spinco, I too was extremely pleased with this move in March 2013 because:
  1. It was going to maximize the impact of rvx-208.
  2. It would protect the Zenith assets and the funding for Zenith research would flow from RVX.
  3. And then a Zenith IPO would occur (last fall).
I thought I would be rich!!! Oh well, that's life and the future looks very promising and those IPOs of private sale will happen!

Clearly, this is an ongoing business.

Thanks as always for the perspectives.
Cheers
Toinv
Bullboard Posts